Placebo-controlled randomised trial with liraglutide on magnetic resonance endpoints in individuals with type 2 diabetes: a pre-specified secondary study on ectopic fat accumulation

Author(s):
Bizino, M.B.; Jazet, I.M.; Heer, P. de; Eyk, H.J. van; Dekkers, I.A. (0000-0002-3329-0660); Rensen, P.C.N. (0000-0002-8455-4988); Paiman, E.H.M.; Lamb, H.J.; Smit, J.W.
Published
2019
Publication type
Article / Letter to editor
Ectopic fatGlucagon-like peptide-1 receptor agonistHepatic steatosisLiraglutideMyocardial steatosisNon-alcoholic fatty liver diseaseType 2 diabetes mellitus
Date issued
2019-11-05
Language
English
Is part of
Diabetologia
hdl
1887/121293
doi
10.1007/s00125-019-05021-6